320 related articles for article (PubMed ID: 33034128)
1. IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival.
Huang Q; Ma X; Wang Y; Niu Z; Wang R; Yang F; Wu M; Liang G; Rong P; Wang H; Harris DC; Wang W; Cao Q
EMBO Mol Med; 2020 Nov; 12(11):e12305. PubMed ID: 33034128
[TBL] [Abstract][Full Text] [Related]
2. Potential correlation of allograft infiltrating group 2 innate lymphoid cells with acute rejection after liver transplantation.
Sun J; Zhou GP; Li SP; Chen XJ; Zhang JM; Jiang YZ; Cui B; Zhang HM; Sun LY; Zhu ZJ
Front Immunol; 2022; 13():953240. PubMed ID: 35967423
[TBL] [Abstract][Full Text] [Related]
3. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
4. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
5. Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury.
Cao Q; Wang R; Niu Z; Chen T; Azmi F; Read SA; Chen J; Lee VWS; Zhou C; Julovi S; Huang Q; Wang YM; Starkey MR; Zheng G; Alexander SI; George J; Wang Y; Harris DCH
JHEP Rep; 2023 Oct; 5(10):100837. PubMed ID: 37691688
[TBL] [Abstract][Full Text] [Related]
6. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
7. Type 2 innate lymphoid cells regulation by regulatory T cells attenuates atherosclerosis.
Gao X; Lin J; Zheng Y; Liu S; Liu C; Liu T; Wang B; He S; Li D
J Mol Cell Cardiol; 2020 Aug; 145():99-111. PubMed ID: 32526223
[TBL] [Abstract][Full Text] [Related]
8. The ST2
Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
[TBL] [Abstract][Full Text] [Related]
9. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.
Cao Q; Wang Y; Niu Z; Wang C; Wang R; Zhang Z; Chen T; Wang XM; Li Q; Lee VWS; Huang Q; Tan J; Guo M; Wang YM; Zheng G; Yu D; Alexander SI; Wang H; Harris DCH
J Am Soc Nephrol; 2018 Mar; 29(3):961-976. PubMed ID: 29295873
[TBL] [Abstract][Full Text] [Related]
10. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function.
Noval Rivas M; Burton OT; Oettgen HC; Chatila T
J Allergy Clin Immunol; 2016 Sep; 138(3):801-811.e9. PubMed ID: 27177780
[TBL] [Abstract][Full Text] [Related]
11. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of IL-33 induces a population of circulating KLRG1
Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ
Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462
[TBL] [Abstract][Full Text] [Related]
13. The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice.
Bahhar I; Eş Z; Köse O; Turna A; Günlüoğlu MZ; Çakır A; Duralı D; Magnusson FC
Front Immunol; 2023; 14():1244437. PubMed ID: 37781372
[TBL] [Abstract][Full Text] [Related]
14. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation.
Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W
J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4
Hu M; Hawthorne WJ; Nicholson L; Burns H; Qian YW; Liuwantara D; Jimenez Vera E; Chew YV; Williams L; Yi S; Keung K; Watson D; Rogers N; Alexander SI; O'Connell PJ
Diabetes; 2020 Aug; 69(8):1735-1748. PubMed ID: 32381646
[TBL] [Abstract][Full Text] [Related]
16. Unique Phenotypes of Heart Resident Type 2 Innate Lymphoid Cells.
Deng Y; Wu S; Yang Y; Meng M; Chen X; Chen S; Li L; Gao Y; Cai Y; Imani S; Chen B; Li S; Deng Y; Li X
Front Immunol; 2020; 11():802. PubMed ID: 32431711
[TBL] [Abstract][Full Text] [Related]
17. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
18. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
19. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis.
Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G
J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212
[TBL] [Abstract][Full Text] [Related]
20. Development and function of regulatory innate lymphoid cells.
Thomas CM; Peebles RS
Front Immunol; 2022; 13():1014774. PubMed ID: 36275689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
